Suppr超能文献

与亚组 A3 相比,感染重组 HIV-1 A3/CRF02_AG 的血清学新发个体向艾滋病的进展和艾滋病相关死亡更快。

Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3.

机构信息

Department of Experimental Medical Science Lund.

出版信息

J Infect Dis. 2014 Mar 1;209(5):721-8. doi: 10.1093/infdis/jit416. Epub 2013 Aug 9.

Abstract

BACKGROUND

Human immunodeficiency virus type 1 (HIV-1) is divided into subtypes and circulating recombinant forms (CRFs) but the impact of subtype/CRF on disease progression is not fully understood.

METHODS

We determined the HIV-1 subtype/CRF of 152 seroincident individuals from Guinea-Bissau, based on the C2-V3 region of env. Disease progression was measured as time from estimated seroconversion to AIDS and AIDS-related death. Hazard ratios (HRs) were calculated using a Cox proportional hazard model, adjusting for gender and age at seroconversion.

RESULTS

The major subtypes/CRFs identified were CRF02_AG (53%), A3 (29%), and A3/02 (a recombinant of A3 and CRF02_AG) (13%). Infection with A3/02 was associated with a close to 3-fold increased risk of AIDS and AIDS-related death compared to A3 (HR = 2.6 [P = 0.011] and 2.9 [P = 0.032], respectively). The estimated time from seroconversion to AIDS and AIDS-related death was 5.0 and 8.0 years for A3/02, 6.2 and 9.0 years for CRF02_AG, and 7.2 and 11.3 years for A3.

CONCLUSION

Our results show that there are differences in disease progression between HIV-1 A-like subtypes/CRFs. Individuals infected with A3/02 have among the fastest progression rates to AIDS reported to date. Determining the HIV-1 subtype of infected individuals could be important in the management of HIV-1 infections.

摘要

背景

人类免疫缺陷病毒 1 型(HIV-1)分为亚型和循环重组形式(CRF),但亚型/CRF 对疾病进展的影响尚不完全清楚。

方法

我们根据 env 基因的 C2-V3 区,确定了来自几内亚比绍的 152 例血清学新发感染者的 HIV-1 亚型/CRF。疾病进展的衡量标准为从估计的血清转换到艾滋病和艾滋病相关死亡的时间。使用 Cox 比例风险模型计算风险比(HR),并调整血清转换时的性别和年龄。

结果

确定的主要亚型/CRF 包括 CRF02_AG(53%)、A3(29%)和 A3/02(A3 和 CRF02_AG 的重组体)(13%)。与 A3 相比,感染 A3/02 与艾滋病和艾滋病相关死亡的风险增加近 3 倍(HR = 2.6[P = 0.011]和 2.9[P = 0.032])。从血清转换到艾滋病和艾滋病相关死亡的估计时间分别为 A3/02 5.0 年和 8.0 年,CRF02_AG 为 6.2 年和 9.0 年,A3 为 7.2 年和 11.3 年。

结论

我们的结果表明,HIV-1 A 样亚型/CRF 之间存在疾病进展差异。感染 A3/02 的个体具有迄今为止报告的艾滋病进展最快的比率。确定感染者的 HIV-1 亚型可能对 HIV-1 感染的管理很重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验